Anakinra efficacy in a Caucasian patient with renal AA amyloidosis secondary to cryopyrin-associated periodic syndrome.
Aït-Abdesselam
Tassadit
T
Lequerré
Thierry
T
Legallicier
Bruno
B
François
Arnaud
A
Le Loët
Xavier
X
Vittecoq
Olivier
O
D000328:Adult; D000686:Amyloidosis / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D056587:Cryopyrin-Associated Periodic Syndromes / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D007678:Kidney Glomerulus / Q000378:metabolism / Q000473:pathology; D009404:Nephrotic Syndrome / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D012074:Remission Induction; D000685:Serum Amyloid A Protein / Q000378:metabolism*; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein; D000685:Serum Amyloid A Protein